Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Luisa Mosti"'
Publikováno v:
Journal of Molecular Modeling. 16:677-691
Novel classes of CB2 agonists based on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine scaffolds have shown high binding affinity toward CB2 receptor and good selectivity over CB1. A computational study of comparat
Autor:
Mario Di Braccio, Debora Bruzzese, Giancarlo Grossi, Paola Fossa, Daniela Piras, Giuliana Leoncini, Maria Grazia Signorello, Giorgio Roma, Luisa Mosti
Publikováno v:
Journal of Medicinal Chemistry. 50:2886-2895
The synthesis and in vitro antiplatelet activity significant data of coumarin derivatives 5i-x and quinolin-2(1H)-one derivatives 22a,b, as well as the corresponding structure-activity relationships are described. The recently reported 8-methyl-4-(1-
Autor:
Angelo Ranise, Francesco Bondavalli, Chiara Casolino, Silvia Schenone, Luisa Mosti, Michele Forina, Paola Fossa
Publikováno v:
Bioorganic & Medicinal Chemistry. 14:1348-1363
In this paper, we are presenting a quantitative-structure–activity relationship (QSAR) study performed on 21 selective A 1 adenosine receptor agonists plus the endogenous substrate, adenosine, so as to identify those predictors which play a key rol
Autor:
Paola Fossa, Angelo Carotti, Cosimo Altomare, Saverio Cellamare, Modesto de Candia, Luisa Mosti
Publikováno v:
European Journal of Pharmaceutical Sciences. 26:78-86
The pH-dependent distribution profiles of a series of pyridin-2(1H)-one analogs of the inotropic/vasodilator agent milrinone, determined in 1-octanol/water (and for a number of them also in chloroform–water) using a pH-metric technique, showed that
Publikováno v:
Bioorganic & Medicinal Chemistry. 13:1393-1402
A series of 2,1,3- and 1,2,4-benzothiadiazine derivatives (BTDs) were synthesized and evaluated for their inhibitory activity versus enzymatic isoforms PDE3, PDE4 and PDE7. The compounds characterized by the 3,5-di-tert-butyl-4-hydroxybenzyl moiety a
Autor:
Silvia Schenone, Paola Fossa, Maurizio Botta, Marina Ziche, Giulia Menozzi, Luisa Mosti, Fabrizio Manetti, Francesco Bondavalli, Olga Bruno, Annalisa Santoro, Angelo Ranise, Sandra Donnini
Publikováno v:
European Journal of Medicinal Chemistry. 39:939-946
Synthesis and biological evaluation of a new class of 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives are reported. A preliminary cellular assay system using the tumor cell line A431 responding to epidermal growth factor (EGF) for its growth,
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 367:109-118
Two mechanisms are responsible for the positive inotropic effect of the cardiotonic drug milrinone, i.e., inhibition of type III cAMP phosphodiesterase (PDE III), and displacement of endogenous adenosine from A(1) inhibitory receptor. Since PDE III i
Autor:
Angelo Ranise, Luisa Mosti, Fabrizio Giordanetto, Francesco Bondavalli, Giulia Menozzi, Silvia Schenone, Paola Fossa
Publikováno v:
Journal of Computer-Aided Molecular Design. 17:39-51
Adenosine is a naturally occurring purine nucleoside that has a wide variety of well-documented regulatory functions and physiological roles. Selective activation of the adenosine A1 receptor has drawn attention in drug discovery for the therapeutic
Publikováno v:
Journal of Computer-Aided Molecular Design. 17:53-64
In PUVA (Psoralen plus UVA) chemotherapy 8-methoxypsoralen is the most widely used compound, although its efficacy is endowed with undesired side effects. In order to have an evident anti-proliferative activity with a reduced phototoxicity, many line
Autor:
Marianna Angiola, M. Ghia, A. Piana, U. Armani, Luisa Merello, Giulia Menozzi, Francesca Mattioli, Luisa Mosti
Publikováno v:
Il Farmaco. 55:219-226
A number of 4-dialkylamino-1-(5-substituted or unsubstituted 1-phenyl-1 H -pyrazol-4-yl)butan-1-ols 2a – n were synthesized and tested in vivo for anti-inflammatory and analgesic activities and in vitro for platelet anti-aggregating activity. Dimet